The Valley Desk

NCT03921021 · Interventional trial

Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma

Overall registry status Completed

Phase 2

Conditions Esophagogastric Adenocarcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov